DEL Enters into Long Term LC02 Offtake with Supagas

Open PDF
Stock Delorean Corporation Ltd (DEL.ASX)
Release Time 17 Mar 2025, 8:21 a.m.
Price Sensitive Yes
 Delorean Enters into Long-Term LCO2 Offtake with Supagas
Key Points
  • Delorean signs binding long-term agreement with Supagas for supply of biogenic food-grade liquid carbon dioxide
  • Supagas will take all the liquid CO2 produced by Delorean's SA1 bioenergy facility in Adelaide
  • LCO2 will conform to ISBT guidelines for 99.99% Food Grade standard
Full Summary

Delorean Corporation Ltd (ASX: DEL) has announced that it has entered into a binding long-term agreement with Supagas Pty Ltd ('Supagas') for the supply of biogenic food-grade liquid carbon dioxide ('LCO2') to be produced from Delorean's SA1 bioenergy facility currently under construction in Edinburgh Parks, near Adelaide in South Australia. Supagas is a leading supplier of LPG, industrial, medical, specialty and helium gases in Australia, owned by Nippon Sanso Holdings Corporation - the fourth largest gas supplier globally. Delorean's SA1 project will process 70,000 tonnes per annum of commercial and municipal organic waste diverted from landfill using anaerobic digestion to produce biogas for renewable electricity and gas. The biogenic LCO2 will be manufactured as a by-product from the further upgrade of biogas to mains-grade biomethane (renewable gas) for injection into the gas network. The long-term contract envisages Supagas taking all the liquid CO2 produced by Delorean, with Delorean providing Supagas access to the SA1 facility for load out and transportation. The LCO2 will conform to International Society of Beverage Technologists (ISBT) guidelines for carbon dioxide purity and quality, at 99.99% Food Grade standard. Pricing for LCO2 under this supply agreement is on commercial market terms, and Delorean and Supagas will share equally any carbon credits generated from the production of biogenic LCO2.

Outlook

The long-term nature of this supply agreement locks in certainty of forward revenues for Delorean with an investment-grade counterparty, and demonstrates the diversity of income streams flowing from the high-yielding build/own/operate infrastructure asset pipeline Delorean is building out, beyond baseline revenues from acceptance of waste and sale of electricity, renewable gas, environmental credits and biofertiliser. Production and sale of LCO2 can be replicated across all of Delorean's near-term, medium-term and longer-term development assets where biomethane upgrade forms part of the project economics.